Experimental method for treating POI by combining Rg1 with hAD-MSCs
An experimental method, the technology of had-mscs, is applied in the field of Rg1 combined with hAD-MSCs in the treatment of POI, which can solve the problems of unsatisfactory transplantation effect and low transplantation homing rate, and achieves a convenient operation, solves clinical problems, and has good promotion prospects. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0020] An experimental method for treating POI with Rg1 combined with hAD-MSCs, comprising the following steps:
[0021] 1) Culture of human amniotic mesenchymal stem cells hAD-MSCs: hAD-MSCs cells were cultured in RPMI 1640 culture medium containing 10% fetal bovine serum FBS, and 1% penicillin-streptomycin was added, and filled with 5% The cells were cultured in a humid 37°C constant temperature cell incubator with CO2, and the cells were continuously passaged at the third generation for subsequent experiments;
[0022] 2) Identification of hAD-MSCs by flow cytometry: Flow cytometry analysis was performed on the surface markers of hAD-MSCs cultured at passage 3 to determine their stem cell characteristics, and the cells were harvested and centrifuged at 250×g at room temperature 5min, then resuspend the cell pellet in PBS to prepare a single cell suspension, and make the cell concentration 1×105 / ml, the cells were mixed with anti-human CD-133, anti-human CD-45, anti-human CD...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
